1 Introduction to Research & Analysis Reports
1.1 Anti Microbial Peptides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti Microbial Peptides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti Microbial Peptides Overall Market Size
2.1 Global Anti Microbial Peptides Market Size: 2022 VS 2029
2.2 Global Anti Microbial Peptides Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti Microbial Peptides Sales: 2018-2029
3 Company Landscape
3.1 Top Anti Microbial Peptides Players in Global Market
3.2 Top Global Anti Microbial Peptides Companies Ranked by Revenue
3.3 Global Anti Microbial Peptides Revenue by Companies
3.4 Global Anti Microbial Peptides Sales by Companies
3.5 Global Anti Microbial Peptides Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti Microbial Peptides Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti Microbial Peptides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti Microbial Peptides Players in Global Market
3.8.1 List of Global Tier 1 Anti Microbial Peptides Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti Microbial Peptides Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti Microbial Peptides Market Size Markets, 2022 & 2029
4.1.2 Plant Anti-Microbial Peptides
4.1.3 Bacterial Anti-Microbial Peptides
4.1.4 Animal Anti-Microbial Peptides
4.1.5 Insects Anti-Microbial Peptides
4.2 By Type – Global Anti Microbial Peptides Revenue & Forecasts
4.2.1 By Type – Global Anti Microbial Peptides Revenue, 2018-2023
4.2.2 By Type – Global Anti Microbial Peptides Revenue, 2024-2029
4.2.3 By Type – Global Anti Microbial Peptides Revenue Market Share, 2018-2029
4.3 By Type – Global Anti Microbial Peptides Sales & Forecasts
4.3.1 By Type – Global Anti Microbial Peptides Sales, 2018-2023
4.3.2 By Type – Global Anti Microbial Peptides Sales, 2024-2029
4.3.3 By Type – Global Anti Microbial Peptides Sales Market Share, 2018-2029
4.4 By Type – Global Anti Microbial Peptides Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti Microbial Peptides Market Size, 2022 & 2029
5.1.2 Personal Care and Cosmetics
5.1.3 Healthcare & Pharmaceuticals
5.1.4 Biotechnology
5.2 By Application – Global Anti Microbial Peptides Revenue & Forecasts
5.2.1 By Application – Global Anti Microbial Peptides Revenue, 2018-2023
5.2.2 By Application – Global Anti Microbial Peptides Revenue, 2024-2029
5.2.3 By Application – Global Anti Microbial Peptides Revenue Market Share, 2018-2029
5.3 By Application – Global Anti Microbial Peptides Sales & Forecasts
5.3.1 By Application – Global Anti Microbial Peptides Sales, 2018-2023
5.3.2 By Application – Global Anti Microbial Peptides Sales, 2024-2029
5.3.3 By Application – Global Anti Microbial Peptides Sales Market Share, 2018-2029
5.4 By Application – Global Anti Microbial Peptides Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti Microbial Peptides Market Size, 2022 & 2029
6.2 By Region – Global Anti Microbial Peptides Revenue & Forecasts
6.2.1 By Region – Global Anti Microbial Peptides Revenue, 2018-2023
6.2.2 By Region – Global Anti Microbial Peptides Revenue, 2024-2029
6.2.3 By Region – Global Anti Microbial Peptides Revenue Market Share, 2018-2029
6.3 By Region – Global Anti Microbial Peptides Sales & Forecasts
6.3.1 By Region – Global Anti Microbial Peptides Sales, 2018-2023
6.3.2 By Region – Global Anti Microbial Peptides Sales, 2024-2029
6.3.3 By Region – Global Anti Microbial Peptides Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti Microbial Peptides Revenue, 2018-2029
6.4.2 By Country – North America Anti Microbial Peptides Sales, 2018-2029
6.4.3 US Anti Microbial Peptides Market Size, 2018-2029
6.4.4 Canada Anti Microbial Peptides Market Size, 2018-2029
6.4.5 Mexico Anti Microbial Peptides Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti Microbial Peptides Revenue, 2018-2029
6.5.2 By Country – Europe Anti Microbial Peptides Sales, 2018-2029
6.5.3 Germany Anti Microbial Peptides Market Size, 2018-2029
6.5.4 France Anti Microbial Peptides Market Size, 2018-2029
6.5.5 U.K. Anti Microbial Peptides Market Size, 2018-2029
6.5.6 Italy Anti Microbial Peptides Market Size, 2018-2029
6.5.7 Russia Anti Microbial Peptides Market Size, 2018-2029
6.5.8 Nordic Countries Anti Microbial Peptides Market Size, 2018-2029
6.5.9 Benelux Anti Microbial Peptides Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti Microbial Peptides Revenue, 2018-2029
6.6.2 By Region – Asia Anti Microbial Peptides Sales, 2018-2029
6.6.3 China Anti Microbial Peptides Market Size, 2018-2029
6.6.4 Japan Anti Microbial Peptides Market Size, 2018-2029
6.6.5 South Korea Anti Microbial Peptides Market Size, 2018-2029
6.6.6 Southeast Asia Anti Microbial Peptides Market Size, 2018-2029
6.6.7 India Anti Microbial Peptides Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti Microbial Peptides Revenue, 2018-2029
6.7.2 By Country – South America Anti Microbial Peptides Sales, 2018-2029
6.7.3 Brazil Anti Microbial Peptides Market Size, 2018-2029
6.7.4 Argentina Anti Microbial Peptides Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti Microbial Peptides Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti Microbial Peptides Sales, 2018-2029
6.8.3 Turkey Anti Microbial Peptides Market Size, 2018-2029
6.8.4 Israel Anti Microbial Peptides Market Size, 2018-2029
6.8.5 Saudi Arabia Anti Microbial Peptides Market Size, 2018-2029
6.8.6 UAE Anti Microbial Peptides Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AnaSpec
7.1.1 AnaSpec Company Summary
7.1.2 AnaSpec Business Overview
7.1.3 AnaSpec Anti Microbial Peptides Major Product Offerings
7.1.4 AnaSpec Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.1.5 AnaSpec Key News & Latest Developments
7.2 Novozymes
7.2.1 Novozymes Company Summary
7.2.2 Novozymes Business Overview
7.2.3 Novozymes Anti Microbial Peptides Major Product Offerings
7.2.4 Novozymes Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.2.5 Novozymes Key News & Latest Developments
7.3 Bachem
7.3.1 Bachem Company Summary
7.3.2 Bachem Business Overview
7.3.3 Bachem Anti Microbial Peptides Major Product Offerings
7.3.4 Bachem Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.3.5 Bachem Key News & Latest Developments
7.4 Phoenix Biotech
7.4.1 Phoenix Biotech Company Summary
7.4.2 Phoenix Biotech Business Overview
7.4.3 Phoenix Biotech Anti Microbial Peptides Major Product Offerings
7.4.4 Phoenix Biotech Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.4.5 Phoenix Biotech Key News & Latest Developments
7.5 AMP Biotech
7.5.1 AMP Biotech Company Summary
7.5.2 AMP Biotech Business Overview
7.5.3 AMP Biotech Anti Microbial Peptides Major Product Offerings
7.5.4 AMP Biotech Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.5.5 AMP Biotech Key News & Latest Developments
7.6 Shanghai Abbiochem Company
7.6.1 Shanghai Abbiochem Company Company Summary
7.6.2 Shanghai Abbiochem Company Business Overview
7.6.3 Shanghai Abbiochem Company Anti Microbial Peptides Major Product Offerings
7.6.4 Shanghai Abbiochem Company Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.6.5 Shanghai Abbiochem Company Key News & Latest Developments
7.7 Ramamoorthy Group
7.7.1 Ramamoorthy Group Company Summary
7.7.2 Ramamoorthy Group Business Overview
7.7.3 Ramamoorthy Group Anti Microbial Peptides Major Product Offerings
7.7.4 Ramamoorthy Group Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.7.5 Ramamoorthy Group Key News & Latest Developments
7.8 Lytix Biopharma
7.8.1 Lytix Biopharma Company Summary
7.8.2 Lytix Biopharma Business Overview
7.8.3 Lytix Biopharma Anti Microbial Peptides Major Product Offerings
7.8.4 Lytix Biopharma Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.8.5 Lytix Biopharma Key News & Latest Developments
7.9 Ai2
7.9.1 Ai2 Company Summary
7.9.2 Ai2 Business Overview
7.9.3 Ai2 Anti Microbial Peptides Major Product Offerings
7.9.4 Ai2 Anti Microbial Peptides Sales and Revenue in Global (2018-2023)
7.9.5 Ai2 Key News & Latest Developments
8 Global Anti Microbial Peptides Production Capacity, Analysis
8.1 Global Anti Microbial Peptides Production Capacity, 2018-2029
8.2 Anti Microbial Peptides Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti Microbial Peptides Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti Microbial Peptides Supply Chain Analysis
10.1 Anti Microbial Peptides Industry Value Chain
10.2 Anti Microbial Peptides Upstream Market
10.3 Anti Microbial Peptides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti Microbial Peptides Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の抗微生物ペプチド市場予測2023-2029：植物用抗菌ペプチド、細菌用抗菌ペプチド、動物用抗菌ペプチド、昆虫用抗菌ペプチド |
| 【英語タイトル】Anti Microbial Peptides Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5664 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：73 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の抗微生物ペプチド市場規模と予測を収録しています。・世界の抗微生物ペプチド市場：売上、2018年-2023年、2024年-2029年 ・世界の抗微生物ペプチド市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の抗微生物ペプチド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「植物用抗菌ペプチド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 抗微生物ペプチドのグローバル主要企業は、AnaSpec、 Novozymes、 Bachem、 Phoenix Biotech、 AMP Biotech、 Shanghai Abbiochem Company、 Ramamoorthy Group、 Lytix Biopharma、 Ai2などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、抗微生物ペプチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の抗微生物ペプチド市場：タイプ別、2018年-2023年、2024年-2029年 世界の抗微生物ペプチド市場：タイプ別市場シェア、2022年 ・植物用抗菌ペプチド、細菌用抗菌ペプチド、動物用抗菌ペプチド、昆虫用抗菌ペプチド 世界の抗微生物ペプチド市場：用途別、2018年-2023年、2024年-2029年 世界の抗微生物ペプチド市場：用途別市場シェア、2022年 ・パーソナルケア&化粧品、医療&医薬品、バイオテクノロジー 世界の抗微生物ペプチド市場：地域・国別、2018年-2023年、2024年-2029年 世界の抗微生物ペプチド市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における抗微生物ペプチドのグローバル売上、2018年-2023年 ・主要企業における抗微生物ペプチドのグローバル売上シェア、2022年 ・主要企業における抗微生物ペプチドのグローバル販売量、2018年-2023年 ・主要企業における抗微生物ペプチドのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AnaSpec、 Novozymes、 Bachem、 Phoenix Biotech、 AMP Biotech、 Shanghai Abbiochem Company、 Ramamoorthy Group、 Lytix Biopharma、 Ai2 ************************************************************* ・調査・分析レポートの概要 抗微生物ペプチド市場の定義 市場セグメント 世界の抗微生物ペプチド市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の抗微生物ペプチド市場規模 世界の抗微生物ペプチド市場規模：2022年 VS 2029年 世界の抗微生物ペプチド市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの抗微生物ペプチドの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の抗微生物ペプチド製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：植物用抗菌ペプチド、細菌用抗菌ペプチド、動物用抗菌ペプチド、昆虫用抗菌ペプチド 抗微生物ペプチドのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：パーソナルケア&化粧品、医療&医薬品、バイオテクノロジー 抗微生物ペプチドの用途別グローバル売上・予測 ・地域別市場分析 地域別抗微生物ペプチド市場規模 2022年と2029年 地域別抗微生物ペプチド売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AnaSpec、 Novozymes、 Bachem、 Phoenix Biotech、 AMP Biotech、 Shanghai Abbiochem Company、 Ramamoorthy Group、 Lytix Biopharma、 Ai2 ... |
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
This report aims to provide a comprehensive presentation of the global market for Anti Microbial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Microbial Peptides. This report contains market size and forecasts of Anti Microbial Peptides in global, including the following market information:
Global Anti Microbial Peptides Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti Microbial Peptides Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti Microbial Peptides companies in 2022 (%)
The global Anti Microbial Peptides market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti Microbial Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Microbial Peptides Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Microbial Peptides Market Segment Percentages, by Type, 2022 (%)
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Global Anti Microbial Peptides Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Microbial Peptides Market Segment Percentages, by Application, 2022 (%)
Personal Care and Cosmetics
Healthcare & Pharmaceuticals
Biotechnology
Global Anti Microbial Peptides Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti Microbial Peptides Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Microbial Peptides revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti Microbial Peptides revenues share in global market, 2022 (%)
Key companies Anti Microbial Peptides sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti Microbial Peptides sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti Microbial Peptides, market overview.
Chapter 2: Global Anti Microbial Peptides market size in revenue and volume.
Chapter 3: Detailed analysis of Anti Microbial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti Microbial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti Microbial Peptides capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の抗微生物ペプチド市場予測2023-2029：植物用抗菌ペプチド、細菌用抗菌ペプチド、動物用抗菌ペプチド、昆虫用抗菌ペプチド] (コード：MMG23JU5664)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の抗微生物ペプチド市場予測2023-2029：植物用抗菌ペプチド、細菌用抗菌ペプチド、動物用抗菌ペプチド、昆虫用抗菌ペプチド]についてメールでお問い合わせ |
